课题基金 / 基金详情

On-Site, Reponsive and Less Invasive Drug Testing In Corrective Services

On-Site, Reponsive and Less Invasive Drug Testing In Corrective Services
惩教服务中的现场、反应灵敏且侵入性较小的药物测试
批准号:
IE230100564
负责人:
Dr David Rudd
金额:
$25.2万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Industry Fellowships
财政年份:
2023
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2023-07-01 至 2025-06-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该项目旨在开发一种新的药物筛选系统,使用纳米材料与先进的质谱相结合,以提高测试速度、成本和准确性,并最大限度地减少与纠正服务中当前药物测试项目相关的困扰。目前,检测项目成本高昂,确认需要数周时间,阻碍了对吸毒和支持服务建议的适当回应。此外,被拘留或接受矫正令的弱势群体发现传统的尿液检测很痛苦,特别是在以前遭受过性暴力的情况下。新的准确、快速的现场唾液检测将彻底改变药物监测,并为惩教管辖区提供澳大利亚设计的解决方案。
英文摘要
This project aims to develop a new drug screening system using nanomaterials interfaced with advanced mass spectrometry to improve testing speed, cost, and accuracy, and minimise the distress associated with current drug testing programs within corrective services. Currently, testing programs are costly, with confirmation taking multiple weeks, preventing appropriate responses to drug use and support service recommendations. Additionally, vulnerable people in custody or on corrective orders find conventional urine testing distressing, especially when previously exposed to sexual violence. New accurate, rapid saliva testing on-site will revolutionise drug monitoring and provide an Australian designed solution for correctional jurisdictions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金